| Noncolorectal Gastrointestinal Cancer |
1 |
0.95 |
| Cancer |
0 |
0.8 |
| Otolaryngology |
0 |
0.66 |
| Colorectal Cancer |
0 |
0.62 |
| Esophageal Cancer |
0 |
0.59 |
| Colorectal Cancer Screening |
0 |
0.57 |
| Genomic Medicine |
0 |
0.5 |
| Helicobacter Pylori |
0 |
0.2 |
| Gastritis |
0 |
0.18 |
| Atrophic Gastritis |
0 |
0.1 |
| Intestinal Metaplasia |
0 |
0.1 |
| Antibiotics |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Esophageal Adenocarcinoma |
0 |
0.04 |
| Esophagus |
0 |
0.04 |
| Genetics |
0 |
0.04 |
| Adenocarcinoma |
0 |
0.02 |
| California |
0 |
0.02 |
| Dysplasia |
0 |
0.02 |
| Endoscopy |
0 |
0.02 |
| Preventive Screening |
0 |
0.02 |
| Resection |
0 |
0.02 |
| Abdomen |
0 |
0.01 |
| Adverse Effects |
0 |
0.01 |
| Bacteria |
0 |
0.01 |
| Bowel Preparation |
0 |
0.01 |
| Chronic Gastritis |
0 |
0.01 |
| Clinician Health and Well-Being |
0 |
0.01 |
| Colonoscopy |
0 |
0.01 |
| Dyspepsia |
0 |
0.01 |
| Face |
0 |
0.01 |
| Gastroesophageal Reflux Disease |
0 |
0.01 |
| Gland |
0 |
0.01 |
| Medical Life |
0 |
0.01 |
| Nausea |
0 |
0.01 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.01 |
| Pain Management |
0 |
0.01 |
| Patient Safety |
0 |
0.01 |
| Proton Pump Inhibitor |
0 |
0.01 |
| Stomach |
0 |
0.01 |
| Tissue |
0 |
0.01 |